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Background: Pediatric tuina is used to prevent and treat disease by employing various manipulative techniques
on specific parts of the body, appropriate to the child’s specific physiological and pathological characteristics.
Objective: To evaluate the effects and safety of pediatric tuina as a non-pharmaceutical therapy for anorexia in
children under 14 years.
Methods: Randomized controlled trials (RCTs) comparing pediatric tuina with medicine for anorexia were in-
cluded in this review. Six electronic databases were searched from inception to June 2019. Two authors in-
dependently extracted data and assessed the risk of bias. Significant effective rate (defined as appetite improved
and food intake returning to 3/4 or more of normal intake) was used as primary outcome. Secondary outcomes
included food intake, compliance and adverse events. Trial sequential analysis (TSA) was used to calculate the
required information size in a meta-analysis and to detect the robustness of the results. Certainty of the evidence
was assessed using the online GRADEpro tool.
Results: Of the included 28 RCTs involving 2650 children, the majority had a high or unclear risk of bias in terms
of allocation concealment, blinding, and selective reporting. All trials compared tuina with western medicine or
Chinese herbs. For significant effective rate, meta-analysis showed that tuina was superior to western medicine
(risk ratio (RR) 1.68, 95 % confidence interval (CI) [1.35, 2.08]) and Chinese herbs (RR 1.36, 95 % CI [1.19,
1.55]). For food intake, 9 trials evaluated it in the form of score (1 points, 2 points, 4 points and 6 points)
calculated according to the reduction degree of food intake. Six points represented the most serious. Meta-
analysis showed tuina was superior to western medicine (mean difference (MD) -0.88, 95 % CI [-1.27, -0.50])
and Chinese herbs (MD -0.69, 95 % CI [-1.00, -0.38]) on lightening the reduction degree of food intake. Two
trials reported compliance and six trials reported no adverse events occurred in pediatric tuina group. TSA for
significant effective rate demonstrated that the pooled data had insufficient power regarding both numbers of
trials and participants.
Conclusions: Low certainty of evidence suggested pediatric tuina was beneficial and safe for the treatment of
anorexia in children under 14 years. Furthermore well-designed RCTs with adequate sample sizes are needed.
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1. Introduction
Pediatric anorexia is an eating disorder of childhood, characterized
by long-term decrease or disappearance of appetite, reduction or even
refusal to eat.1 Children of all ages may suffer from this disease, espe-
cially children aged 1–6, and can affect up to 45 % of children.2,3 An-
orexia in children may lead to malnutrition, conditions such as rickets
and scurvy, and may delay growth, effect cognitive ability and im-
munity, if it cannot be resolved it can last for a long time.4,5 Western
medicine for anorexia mainly focuses on treatment with gastric motility
drugs, trace elements (e.g. zinc) and vitamin preparations.6 However,
western medicine may cause side effects, and vitamins may lead to
imbalances for example too much zinc may lead to anemia and neu-
tropenia.7,8 Traditional Chinese medicine (TCM) treatments include,
Chinese herbal therapy and non-pharmaceutical treatment such as
acupuncture, cupping and tuina (Chinese massage).9
Parents are often aware of the possible harmful nature of drugs on
their children,10 and in China, both parents and doctors try to explore
non-pharmaceutical treatment options such as pediatric tuina. Pediatric
tuina is guided by the basic theory of TCM, according to the physio-
logical and pathological characteristics of the child. Various manip-
ulative techniques such as spine pinching are used on specific parts of
the child’s body, in order to prevent and treat pediatric diseases.11,12
Tuina has benefits in the treatment of many children's diseases, such as
diarrhea, anorexia, torticollis, cerebral palsy, enuresis, etc.13
Many clinical studies on pediatric tuina for anorexia in children
under 14 years have been conducted. This review aimed to system-
atically review the results of randomized controlled trials (RCTs) with
pediatric tuina versus medicine or no treatment for anorexia in children
under 14 years, and to evaluate the effects and safety of pediatric tuina
for anorexia.
2. Methods
Protocol of this review was registered in PROSPERO
(CRD42018105819) on August 15th 2018 and is available from: http://
www.crd.york.ac.uk/PROSPERO/.
2.1. Inclusion and exclusion criteria
Inclusion criteria were as follows: 1) randomized controlled trial
(RCT); 2) participants younger than or equal to 14 years old, but there
were no gender or race restrictions, and they had to be diagnosed as
anorexia for at least two weeks14; 3) studies compared pediatric tuina
alone to medicine or no treatment. The types of pediatric tuina mainly
include acupoint massage, abdominal massage, spinal pinching, etc.
Exclusion criteria were as follows: 1) Anorexia caused by drugs,
iatrogenic factors, and/or other diseases; 2) Children with moderate to
severe malnutrition, organic disease, mental illness or serious compli-
cations were also excluded; 3) the full text of the literature could not be
obtained; (4) the literature was suspected of plagiarism; 5) any dupli-
cated literature.
2.2. Search strategy
PubMed, the Cochrane Library, EMBASE, China National
Knowledge Infrastructure (CNKI), Wanfang Database and VIP Database
were searched from inception to June 2019. Language was limited to
English and Chinese. The terms tuina or massage or rubbing abdomen
or chiropractic or technique or spinal manipulation combined with
anorexia were used for the search, and the search strategies were ad-
justed for use in the different databases. Details of the six databases are
shown in Appendix 1.
2.3. Study selection and data extraction
One author (SBL) imported the retrieved bibliography citations into
NoteExpress V3.0.4.6732, and duplicates were deleted. Two authors
(SBL and JL) selected the potential eligible articles based on the reading
of titles and abstracts. Full texts screening and data extraction was
conducted afterwards by two authors (SBL and QHC) independently. If
there was any uncertainty or discrepancy, a third author (JPL) was
consulted.
2.4. Outcomes
Significant effective rate was used as the primary outcome.
Significant effective was defined as the appetite improving and food
intake returning to three quarters or more of the normal intake.
Significant effective rate = (the number of significant effective parti-
cipants / total number of participants) × 100 %.
Secondary outcomes included food intake, adverse events and
compliance with interventions. Food intake was evaluated in the form
of score according to the efficacy evaluation criteria in guidance prin-
ciple of clinical study on new drug of traditional Chinese medicine15.
The score was calculated according to the reduction degree of food
intake: 1) 0 points: the reduction of food intake< 1/4 of normal food
intake; 2) 2 points: 1/4 of normal≤ the reduction< 1/3 of normal; 3)
4 points: 1/3 of normal ≤ the reduction<1/2 of normal; 4) 6 points:
the reduction ≥ 1/2 of normal. The higher the score, the more serious
the reduction degree of food intake. Six points represented the most
serious.
2.5. Risk of bias assessment
The risk of bias of the included trials was assessed independently by
two authors (BYL and YPZ) using the risk of bias tool recommended by
the Cochrane Collaboration.16 The items included random sequence
generation, allocation concealment, blinding of participants and per-
sonnel, blinding of outcome assessment, incomplete outcome data, se-
lective reporting and other bias (assessed according to comparability of
baseline data). We judged each item and categorized them into three
levels: low risk of bias, high risk of bias and unclear risk of bias.
2.6. Data synthesis
All statistical analyses were performed using Review Manager
(RevMan) Version 5.3 17. We presented binary data as a risk ratio (RR)
with 95 % confidence interval (CI), and continuous data as a mean
difference (MD) with 95 % CI. Meta-analysis was conducted if the trials
had acceptable statistical heterogeneity and similar clinical character-
istics. The clinical heterogeneity was assessed by evaluating similarities
of the participants and interventions, as well as the outcomes measured
in the included studies and the methodological heterogeneity was as-
sessed by evaluating variability in study design and risk of bias. Con-
sidering potential sources of clinical heterogeneity, the random-effect
model (REM) was used for meta-analysis. Furthermore, statistical het-
erogeneity among the included trials was evaluated using the Chi2 test
and I-square(I²) statistic.18 If P<0.10, there is heterogeneity among
the included studies. when I2> 50 %, it may represent a considerable/
high heterogeneity among the studies,18,19 then subgroup analysis or
sensitivity analysis (based on patients’ population, interventions and
control, outcomes, and methodological difference) were conducted if
data available. We planned to merge the data for all children with
anorexia in a single meta-analysis for the same outcome from the same
comparison. We planned to conduct the following subgroup analyses if
appropriate: 1) subgroup analysis based on different treatment courses,
such as short courses of treatment (≤15 days), medium courses of
treatment (16−30 days), and long courses of treatment (< 30 days), to
detect whether patients can benefit more from long-term treatment; 2)
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subgroup analysis was conducted by gender to detect whether gender
affected the efficacy of tuina, such as whether male children with an-
orexia were better treated than female children with anorexia.
Besides, a funnel plot was performed to explore the possibility of
publication bias, if ten or more trials were included in a meta-analysis
for primary outcomes.20,21 Certainty of evidence for each key outcome
was assessed using GRADE (Grading of Recommendations Assessment,
Development and Evaluation criteria) approach to conduct manage-
ment recommendations22 by the GRADEpro guideline development tool
(GDT) online (https://gradepro.org/). If there were more than 8 trials
in a meta-analysis for primary outcomes, the trial sequential analysis
(TSA) were used to calculate the required information size (based on
two-sided tests with a type I error of 5%, a power of 80 %) in the meta-
analysis and to test the robustness of the results.23,24
3. Results
3.1. Study selection
A total of 2076 records were identified of which 2048 were ex-
cluded for various reasons by screening the titles, abstracts and full-
texts. Finally, 28 trials 25–52 involving 2650 participants were included
in this review. A flow diagram of the study selection process is shown in
Fig.1.
3.2. Study characteristics
Table 1 shows the characteristics of the included 28 trials.
The trials were all conducted in China and published between 2007
and 2019. Only three trials26,39,44 reported sources of funding. Of all the
trials, 25 trials25–37,40–41,43–52 were two-armed, 2 trials38,42 had three-
arms and the remaining one39 was a four-armed trial. In total, 2619
participants were included in the data analysis and of these 1248 were
in the tuina group. Ratio of male to female was about 1.13 : 1 based on
25 trials26–39,41–50,52 reporting this information. The average age of
participants was 4 months to 14 years according to 17
trials.26–27,29–32,34,36,38,41,44,46–48,50–52 The duration of anorexia was 2
weeks to 4 years based on 13 trials.29–31,34–35,38–39,44,46–47,50–52 Only
one trial41 reported the severity of the disease. The treatment duration
of tuina for majority included trials mainly varied from 7 days to 15
days, and the frequency for all included trials was once a day.
In summary, there were two categories of comparisons among all
the included trials. One was tuina compared with western medicine
(mainly included vitamin preparations and trace elements, e.g. zinc),
and the other was tuina compared with Chinese herbs (Chinese patent
medicine or Chinese medicine decoction for enhance stomach digestive
function, e.g. Jianwei Xiaoshi Oral Solution, Sijunzi Decoction and
Yigong San Granules, et al).
3.3. Assessment of risk of bias
In terms of the random sequence generation methods of the
Fig. 1. Flow diagram of searches and study selection.
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included 28 trials, 11 trials27–28,33,34,37,39,43–44,48,52 used random
number tables, two trials47,50 used lot-drawing, one trial42 used Excel
software and the remaining 14 trials25–26,29–32,34,36,38,40–41,46,49,51 only
mentioned random or randomization without describing the specific
randomization methods. In terms of allocation concealment, only one
trial 37 performed this by using a sealed, opaque envelope. Therefore,
the risk of selection bias was unclear for the majority of the included
trials due to insufficient information being available on random se-
quence generation and allocation concealment. The risk of performance
bias was high for all included trials due to absence of blinding to par-
ticipants and personnel. Only three trials 37,39,43 performed blinding
regarding the outcome assessment and the remaining 25
trials25–36,38,40–42,44–52 did not report relevant information, thus the risk
of detection bias for majority of the included trials was unclear. In
terms of attrition bias, 24 trials26–30,32–35,37–44,46–52 were assessed as
low risk due to complete outcome data or incomplete outcome data
being adequately addressed, and the remaining four trials25,31,36,45
were assessed as high risk due to incomplete outcome data that were
not adequately addressed. Since all protocols or registration informa-
tion of the included trials were not available, the reporting bias for all
trials was assessed as unclear. All 28 trials reported the comparability of
baseline data, so they were assessed as having low risk of other bias.
Fig.2 demonstrates the risk of bias of included 28 trials.
3.4. Effects of interventions
All the included trials reported the primary outcome of significant
effective rate, 9 trials25–26,32–33,36–37,42–43,45 reported food intake, six
trials25,34–35,36,38,45 reported adverse events information and two
trials43,49 reported compliance with interventions. We conducted a
subgroup analysis according to different courses of treatment. We were
unable to perform a subgroup analysis based on gender because a mixed
population of male and female children with anorexia in all included
trials.
3.4.1. Primary outcome of significant effective rate
3.4.1.1. Comparison 1: tuina compared with western medicine. A pooled
results showed that tuina was superior to western medicine (RR 1.68,
95 % CI [1.35, 2.08], 12 RCTs38–39,42,44–52 involving 1116 participants).
As P = 0.0002<0.10, I2 = 69 %<50 %, subgroup analysis was
conducted according to the treatment duration: for short courses of
treatment, nine trials38–39,42,44–45,47,49–50,52 showed that tuina was also
more beneficial compared with western medicine (RR 1.77, 95 % CI
[1.34, 2.34]); for medium courses of treatment, one trial51 showed that
there was no statistically difference (RR 1.26, 95 % CI [0.70, 2.30])
between tuina and western medicine; for long courses of treatment, one
trial46 showed that tuina had a better effect than western medicine (RR
1.76, 95 % CI [1.15, 2.71]). One trial48 reported seven to twenty-one
days of treatment (both short and medium courses of treatment) and
showed that there was no statistically difference (RR 1.33, 95 % CI
[0.87, 2.04]) between tuina and western medicine. Fig.3 illustrates the
details of these results.
3.4.1.2. Comparison 2: tuina compared with Chinese herbs. A pooled
results showed that tuina was superior to Chinese herbs (RR 1.36, 95 %
CI [1.19, 1.55], 19 RCTs25–43 involving 1676 participants). As P =
0.0005<0.10, I2 = 60 %<50 %, subgroup analysis was conducted
according to the treatment duration: for short courses of treatment, a
meta-analysis of data from 13 trials26–30,32,35–36,38–40,42–43 showed that
tuina was more beneficial than Chinese herbs (RR 1.25, 95 % CI [1.09,
1.44]); for medium courses of treatment, a meta-analysis of data from 5
trials25,33–34,37,41 showed that tuina was more effective than Chinese
herbs (RR 1.66, 95 % [CI 1.20, 2.28]); for long courses of treatment, no
trial reported this outcome; one trial31 did not report the treatment
course and showed that tuina was more beneficial than Chinese herbs
(RR 1.47, 95 % CI [1.09, 1.99]). Fig.4 illustrates details of these results.
3.4.2. Secondary outcomes
3.4.2.1. Food intake
3.4.2.1.1. Comparison 1: tuina compared with western medicine. Only
2 trials reported this outcome, and both were short courses of
treatment. A pooled data of the two trials42,45 showed that tuina was
superior to western medicine (MD -0.88, 95 % CI [-1.27, -0.50]) on
lightening the reduction degree of food intake. Fig.5 illustrates details
of the result.
3.4.2.1.2. Comparison 2: tuina compared with Chinese herbs. A
pooled date of 8 trials25–26,32–33,36–37,42–43 showed that tuina was
better than Chinese herbs (MD -0.69, 95 % CI [-1.00, -0.38]) on
lightening the reduction degree of food intake. As P = 0.02< 0.10, I2
= 58 %<50 %, subgroup analysis was conducted according to the
treatment duration: for short courses of treatment, a meta-analysis of 5
trials26,32,36,42–43 showed that tuina was more beneficial than Chinese
herbs (MD -0.61, 95 % CI [-1.06, -0.16]); for medium courses of
treatment, a meta-analysis of data from 3 trials25,33,37 showed that
tuina was better than Chinese herbs (MD -0.81, 95 % CI [-1.21, -0.41]);
for long courses of treatment, no trial reported this outcome. Fig.6
illustrates details of these results.
3.4.2.2. Adverse events. In total, six trials25,34–35,37,39,45 reported
adverse event information. Of these, 5 trials25,34,37,39,45 reported no
adverse events occurring in either the tuina or the medicine group. One
trial34 reported 5 cases with adverse events (two bloating, one nausea
and two vomiting) occurred in Chinese herbs group and no adverse
events occurred in tuina group.
3.4.2.3. Compliance with interventions. Two trials43,49 reported this
outcome. One trial49 reported that all patients included had
cooperated in completing the trial. Another trial43 reported that some
patients had poor compliance and could not complete half of the
treatment course and dropped out of the trial.
Fig. 2. Risk of bias of all the included studies.
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3.5. Certainty of evidence by GRADE
Certainty of evidence for key outcomes were all evaluated as low or
very low. Table 2 showed the details of the certainty of available evi-
dence. The certainty of evidence was downgraded mainly due to the
following three reasons: high risk of bias (such as no trial achieved
blinding to participants and personnel); inevitable clinical hetero-
geneity between studies, such as variable level of specialist expertise
and intensity of tuina in comparator conditions; only one trial with
small sample size was included.
3.6. Trial sequential analysis
TSA of 19 trials comparing tuina with Chinese herbs for significant
effective rate showed that the Z-curve (blue dashed line) crossed the
lower 1.96 (black solid line) and the trial sequential monitoring
boundary for benefit (lower red solid line), but not the TSA required
information size (= 3041, vertical red line), as shown in Fig.7-A. This
indicates that tuina for children with anorexia may be encouraging, but
we did not have sufficient power to confirm the conclusion before ac-
quired information size of 3041 participants (that mean the sample size
was not large enough for confirm the conclusion).
TSA of 12 trials comparing tuina with western medicine for sig-
nificant effective rate also showed that the Z-curve (blue dashed line)
crossed the lower 1.96 (black solid line) and the trial sequential mon-
itoring boundary for benefit (lower red solid line), but not the TSA
required information size (= 3248, vertical red line), as shown in Fig.7-
B. This indicates that tuina for children with anorexia may be a po-
tentially useful treatment, but we did not have enough power to con-
firm the conclusion before acquired information size of 3248 partici-
pants.
3.7. Funnel plot analysis
Funnel plot analysis (see Fig.8) was conducted for two comparisons
(tuina versus western medicine or Chinese herbs) separately, due to the
number of RCTs included in each meta-analysis was more than ten. As
can be seen from the figure, both funnel plots (Fig.8-A and Fig.8-B) are
asymmetrical, and the degree of asymmetry of Fig.8-A is more obvious.
This demonstrates that publication bias probably existed in the in-
cluded literature.
4. Discussion
4.1. Summary of the main findings
Twenty-eight RCTs involving 2650 participants (complete data sets
were available for 2619 participants for use in the data analysis) were
included in this review. The results of this review showed that tuina was
better than western medicine or Chinese herbs on increasing significant
effective rate and food intake for anorexia in children under 14 years.
Subgroup analysis according to different courses of treatment showed
Fig. 3. Forest plot comparison between pediatric Tuina versus western medicine on significant effective rate.
S.-B. Liang, et al. Complementary Therapies in Medicine 51 (2020) 102411
6
that the longer the course of treatment, the greater possible benefits of
tuina and that, tuina was safe for children with anorexia. However,
sufficient evidence to confirm the conclusion on safety is still required.
4.2. Comparison with previous studies
A previous review53 showed that the total clinical effective rate of
tuina group was higher than that of control group. Our review analyzed
the significant effective rate, and the result showed that tuina group
was better than that of control group. In addition, our review analyzed
improvement of main symptom (food intake), safety outcomes (adverse
reactions/events) and compliance. Furthermore, our review conducted
subgroup analyses based on different treatment courses. The search
date for the previous systematic review was up to December 2016, and
our review was up to June 2019.
4.3. Limitations
This review not only draws conclusions about the total clinical ef-
fective, but also on the main symptom (food intake), safety outcomes
(adverse reactions/events) and compliance. In addition, the subgroup
analysis was performed based on treatment duration in this review.
These are more comprehensive and conducive to guiding the clinical
application of tuina in the treatment of anorexia.
Fig. 4. Forest plot comparison between pediatric Tuina versus Chinese herbs on significant effective rate.
Fig. 5. Forest plot comparison between pediatric Tuina versus western medicine on food intake.
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There are also some limitations. First, although the included studies
used pediatric tuina, there may be some differences in the choice of the
massage site or technique for each study. Another potential limitation
of this review was the language restriction for literature searching. Due
to resource constraints, other language publications such as Japanese or
Korean were not retrieved, which may have missed some relevant trials.
4.4. Implications for clinical practice
For children with anorexia, oral medication is difficult. Tuina, as a
non-pharmaceutical therapy, can help children with anorexia to over-
come this problem. Moreover, this review found that tuina was more
beneficial in treating anorexia in those under 14 years than western
medicine and Chinese herbs. Also, tuina was safe. Therefore, tuina may
be a good choice for anorexia in children under 14 years, especially for
children with poor medication compliance. According to the course of
treatment of the included trials, it is recommended that children with
anorexia should be treated with tuina for at least 2 weeks. The fre-
quency of treatment is once a day or 6 days a week. However, current
evidence is insufficient to directly guide the clinical use of tuina due to
potential bias and the poor quality of included trials. Also, all the in-
cluded studies were conducted in China, and different countries have
different definition and diagnostic criteria for pediatric anorexia.
Therefore, whether this evidence is equally applicable to other coun-
tries outside China requires further studies in other countries.
4.5. Implications for future research
One of the main reasons for the decline in evidence grade is the high
risk of bias caused by the poor methodological quality of the included
studies. Future studies should pay more attention to research metho-
dology, such as randomization (including the correct generation of
random sequences and the effective implementation of random allo-
cation concealment), blinding, estimation of sample size, missing data
management and so on. One of big challenge for the trial of tuina is
blinding. It is very difficult to blind the patients to avoid performance
bias is because of the particularity of tuina. But in our systematic re-
view, the participants were all children under 14 years, so clinically, the
influence of lack of blinding could be less than that on adult partici-
pants. But we still have the problem that the influence of their parents is
unavoidable in terms of efficacy evaluation, such as the efficacy
evaluation of food intake, parents who tend to give their children
medication but are assigned to the tuina group may deliberately un-
derestimate the effect of tuina. However, the blinding of outcome as-
sessment would be possible in such trials and it could help to avoid
detection bias during the assessment of significant effective rate and
food intake, so to avoid overestimate of the results. Small sample size is
also one of the main reasons for the decline of evidence grade.
Furthermore, the results of TSA indicated that a firm conclusion of the
effectiveness of tuina cannot be reached before acquired information
size. Therefore, large sample, multi-center RCTs should be conducted in
the future.
In addition, most studies only treated participants for short-term or
medium-term treatment, but not for long-term treatment. Moreover,
most studies did not follow up the participants after treatment to ob-
serve the recurrence rate. Therefore, it is suggested that future studies
should be longer (in addition to long-term treatment of subjects, long-
term follow-up after treatment should be conducted to identify recur-
rence). Safety is also important for application of tuina, but most of
included RCTs did not report this outcome. So, future studies should
aware of this and report the safety outcome.
5. Conclusion
Low or very low certainty of evidence suggested pediatric tuina was
beneficial and safe for the treatment of anorexia in children under 14
years. Furthermore well-designed RCTs with adequate sample sizes are
needed.
Author’s contribution
JPL and SBL conceived and designed the review. SBL, QHC and JL
were responsible for the searching, screening and selecting studies. SBL
and QHC participated in data extraction. BYL and YPZ assessed the risk
of bias of the included trials. SBL performed the statistical analysis.
BYL, HJC and XB helped to perform the statistical analysis. SBL drafted
the manuscript. JPL, HJC, YC and NR were all involved in critically
revising the manuscript. All authors have read and approved the final
manuscript. All authors approved the final version of the article, in-
cluding the authorship list.
Fig. 6. Forest plot comparison between pediatric Tuina versus Chinese herbs on food intake.
S.-B. Liang, et al. Complementary Therapies in Medicine 51 (2020) 102411
8
Funding
JPL is supported by the Key Project of the National Natural Science
Foundation of China (No.81830115). NR is funded by Overseas
Expertise Project, Ministry of Education of China (MS20080009).
Conflicts of interest
All authors declare that they have no conflicts of interest concerning
this article.
Statement
All data included in this review were supported by six open
electronic databases for published studies. Details of the six databases
were showed in Appendix 1.
Acknowledgements
We greatly thank Ya-Peng Chou (from Centre for First Teaching
Hospital of Tianjin University of Traditional Chinese Medicine), Qian Li
(from Longhua Hospital of Shanghai University of Traditional Chinese
Medicine) and Jun-Mei Zhou (from Shanghai University of Traditional
Chinese Medicine), for their guidance on expertise related anorexia.
Table 2
GRADE evaluation form of evidence certainty.
Patient or population:children with anorexia
Setting: outpatients and wards
Intervention: pediatric Tuina comparison: medicine therapy
Outcomes No. of participants
(studies)
Certainty of the evidence
(GRADE)
Anticipated absolute effectsa (95% CI) Relative effect (95 % CI)
Risk with Tuina Risk with control
group
Significant effective rate
• Tuina versus western medicine 1117 (12 RCTs) ⨁⨁◯◯1,2
(Low)
655 per 1000 (526–810) 390 per 1000 RR 1.68 (1.35–2.08)
- -Short courses of treatment (≦15
days)
871 (9 RCTs) ⨁⨁◯◯1,2
(Low)
692 per 1000 (524–914) 391 per 1000 RR 1.77 (1.34–2.34)
- -Medium course of treatment
(16−30 days)
76 (1 RCTs) ⨁⨁◯◯1,3
(Low)
409 per 1000 (227–746) 324 per 1000 RR 1.26 (0.70–2.30)
- -Long course of treatment (> 30
days)
90 (1 RCTs) ⨁⨁◯◯1,3
(Low)
665 per 1000 (434 to 1000) 378 per 1000 RR 1.76 (1.15–2.71)
- -Seven to twenty-one days of
treatment
80 (1 RCTs) ⨁⨁◯◯1,3
(Low)
599 per 1000 (392–918) 450 per 1000 RR 1.33 (0.87–2.04)
• Tuina versus Chinese herbs 1676 (19 RCTs) ⨁⨁◯◯1,2
(Low)
735 per 1000 (643–838) 541 per 1000 RR 1.36 (1.19–1.55)
- -Short courses of treatment (≦15
days)
1263
(13 RCTs)
⨁⨁◯◯1,2
(Low)
710 per 1000
(619–818)
568 per 1000 RR 1.25
(1.09–1.44)
- -Medium course of treatment
(16−30 days)
325 (5 RCTs) ⨁⨁◯◯1,3
(Low)
704 per 1000 (575–864) 432 per 1000 RR 1.63 (1.33–2.00)
- -Long course of treatment (> 30
days)
None
- -Did not report the treatment course 88 (1 RCTs) ⨁⨁◯◯1,3
(Low)
820 per 1000 (608 to 1000) 558 per 1000 RR 1.47 (1.09–1.99)
Food intake
• Tuina versus western medicine 125 (2 RCTs) ⨁◯◯◯1,2,3
(Very low)
MD 0.88 lower (1.27 lower to
0.5 lower)
- Short courses of treatment (≦15
days)
125 (2 RCTs) ⨁⨁◯◯1,3
(Low)
MD 0.88 lower (1.27 lower to
0.5 lower)
- Medium course of treatment
(16−30 days)
None
- Long course of treatment (> 30
days)
None
• Tuina versus Chinese herbs 529 (8 RCTs) ⨁⨁◯◯1,2
(Low)
MD 0.69 lower (1 lower to 0.38
lower)
- Short courses of treatment (≦15
days)
350 (5 RCTs) ⨁⨁◯◯1,2
(Low)
MD 0.61 lower (1.06 lower to
0.16 lower)
- Mediun course of treatment
(16−30 days)
179 (3 RCTs) ⨁◯◯◯1,2,3
(Very low)
MD 0.77 lower (1.08 lower to
0.47 lower)
- Long course of treatment (> 30
days)
None
GRADE Working Group grades of evidence.
Low certainty (⨁⨁◯◯): Our confidence in the effect estimate is limited. The true effect may be substantially different from the estimate of the effect;
Very low certainty (⨁◯◯◯): We have very little confidence in the effect estimate. The true effect is likely to be substantially different from the estimate of effect.
Reason for the downgrade of evidence: 1. high risk of performance bias (no trial achieved blinding to participants and personnel); 2. Inevitable clinical heterogeneity
between studies, such as variable level of specialist expertise and intensity of Tuina in comparator conditions; 3. only one trial with small sample size was included.
No.: number; CI: Confidence interval; RR: Risk ratio; MD: Mean difference; RCT: randomized controlled trial.
a The risk in the intervention group (and its 95 % confidence interval) is based on the assumed risk in the comparison group and the relative effect of the
intervention (and its 95 % CI).
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Appendix 1 Search strategy for six open electronic databases
Databases Search strategy
CNKI #1: SU = ‘Tuina(推拿)’ + ‘Anmo(按摩)’ + ‘Shoufa(手法)’ + ‘Nieji(捏脊)’ + ‘Mofu(摩腹)’
#2: SU = ‘Yanshi(厌食)’ + 'Xiaoeryanshi(小儿厌食)' + 'Ertongyanshi(儿童厌食)'
#3: #1 AND #2
Wanfang #1: Major Topic:"Tuina(推拿)" + Major Topic:"Anmo(按摩)" + Major Topic:"Shoufa(手法)" + Major Topic:"Nieji(捏脊)" + Major Topic:"Mofu(摩腹)"
#2: Major Topic:"Yanshi(厌食)" + Major Topic:"Xiaoeryanshi(小儿厌食)" + Major Topic:"Ertongyanshi(儿童厌食)"
#3: #1 AND #2
VIP #1: M = Tuina(推拿) OR M = Anmo(按摩) OR M = Shoufa(手法) OR M = Nieji(捏脊) OR M = Mofu(摩腹)
#2: M = Yanshi(厌食) OR Xiaoeryanshi(小儿厌食) OR Ertongyanshi(儿童厌食)
#3: #1 AND #2
PubMed #1: (Tuina OR massage OR rubbing abdomen OR technique OR chiropractic OR spinal manipulation[MeSH Major Topic])
#2: (anorexia OR childhood anorexia OR infantile anorexia[MeSH Major Topic])
#3: #1 AND #2
Embase #1: ('tuina':ti OR 'massage':ti OR 'rubbing abdomen':ti OR 'chiropractic':ti OR 'technique':ti OR 'spinal manipulation':ti)
#2: ('anorexia':ti OR 'childhood anorexia':ti OR 'infantile anorexia':ti)
#3: #1 AND #2
The cochrane library #1: (Tuina OR massage OR rubbing abdomen OR chiropractic OR technique OR spinal manipulation):ti,ab,kw
#2: (anorexia OR childhood anorexia OR infantile anorexia):ti,ab,kw
#3: #1 AND #2
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